CLINICAL_TRIALS trial_result · 2018-09-06

Clinical Trial Update: The Exploration of Optimal Treatment Scheme in Patients With Type 2 Diabetes Inadequately Controlled With Glargine [Phase 4]

A Phase 4 clinical trial exploring optimal treatment strategies for patients with type 2 diabetes inadequately controlled with glargine.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Type2 Diabetes | Phase 4 | Status: UNKNOWN